Introduction
============

Systemic lupus erythematosus (SLE) is a common autoimmune disease that adversely affects multiple organs. Pleuritis occurs in 43% of patients diagnosed with SLE ([@B1]) and is often associated with chest pain, with or without pleural effusion. However, pleural effusion as the initial presenting clinical sign of SLE is rare, occurring in only 1% of patients during the course of disease ([@B2]). This makes the diagnostic process more complex, and can lead to incorrect diagnoses. We herein report four cases in which SLE patients presented with pleuritis as the initial manifestation of disease and review the pertinent literature on similar adult cases.

Case Reports
============

Case 1
------

A 75-year-old man with a past medical history of coronary artery bypass grafting (CABG), chronic heart failure, chronic obstructive pulmonary disease, chronic kidney disease and type 2 diabetes presented to our outpatient clinic with a 3-week history of progressive dyspnea and productive cough despite treatment for congestive heart failure. He also had a slight fever (37.0℃), leukocytosis (17,100/μL) and bilateral pleural effusion on a thoracic radiograph. The patient was admitted to our hospital with a tentative diagnosis of heart failure exacerbated by acute bronchitis, and antimicrobial and diuretic therapy were initiated. The initial treatments were, however, ineffective and the pleural effusion progressed. Echocardiography and cardiac catheterization showed no evidence of left-sided congestive heart failure or pulmonary arterial hypertension. Contrast-enhanced computed tomography was negative for pulmonary thromboembolism. Thoracentesis revealed lymphocytic exudate without evidence of malignancy, and microbiologic cultures were negative. The pleural effusion adenosine deaminase (ADA) level was 54.2 U/L (8.6-20.5). Pancytopenia and urinary red blood cell casts were also identified, leading to a differential diagnosis of SLE. Further laboratory testing revealed rising anti-double stranded DNA (anti-dsDNA) antibody levels \[7 ng/dL, (0-6)\] and hypocomplementemia, confirming a diagnosis of SLE pleuritis. The administration of methylprednisolone (60 mg, daily) improved his general condition and enabled him to be successfully discharged from the hospital.

Case 2
------

A 69-year-old man with a past medical history of ulcerative colitis and CABG for myocardial infarction presented to our hospital with a 3-month history of exertional dyspnea. A chest X-ray image showed bilateral pleural effusion. Thoracentesis revealed lymphocytic exudate without evidence of malignancy, and microbiologic cultures were negative. A high ADA level was noted (89.0 U/L), and thoracoscopy was performed. No evidence of tuberculosis or cancer was identified and pleural biopsy showed only lymphocytic infiltration. Further investigations revealed anti-nuclear antibody (ANA), anti-dsDNA antibody \[95 ng/dL, (0-6)\], and anti-phospholipid antibody positivity, leading to the diagnosis of SLE. His symptoms and pleural effusion improved after the administration of methylprednisolone (60 mg, every other day).

Case 3
------

An 80-year-old woman with a past medical history of right-sided breast cancer and scleroderma was referred for further evaluation of bilateral pleural effusion. Thoracentesis revealed lymphocyte-predominant exudate without evidence of malignancy, and microbiologic cultures were negative. The ADA level was 22.5 U/L. Further evaluation revealed proteinuria, hypocomplementemia, and leukopenia. Tests for ANA revealed positive results, confirmed that SLE was the cause of her pleuritis. The administration of methylprednisolone (30 mg, daily) improved her general condition.

Case 4
------

An 83-year-old man with a 30-year history of hypertension, hyperlipidemia, diabetes, and chronic kidney disease who had undergone CABG for angina twenty years previously presented to our division for a routine checkup after recovering from Legionella pneumonia. Investigations revealed bilateral pleural effusion and a slightly elevated C-reactive protein level (2.47 mg/dL). Thoracentesis revealed lymphocytic exudate without evidence of malignancy, and microbiologic cultures were negative. The level of ADA in the patient\'s plural effusion was elevated (175.1 U/L). Thoracoscopy revealed no evidence of tuberculosis or cancer and pleural biopsy showed only lymphocytic infiltration. Further testing revealed anti-dsDNA antibody \[33 ng/dL, (0-6)\] positivity. We strongly suspected SLE and began administering aspirin (400 mg, daily) as a diagnostic treatment, after which his pleural effusion disappeared. One year later, his ANA titer became positive (1:80, homogenous) and his dsDNA antibody level increased to 84 ng/dl (0-6). We therefore thought that SLE was the most likely diagnosis.

Discussion
==========

The four SLE patients described in this report presented with pleuritis as their initial clinical sign. In all four patients, testing unrelated to the pleural effusion ultimately led to the diagnosis of SLE.

Although pleuritis is a common feature of SLE, Dubois et al. showed that pleuritis associated with or without effusion occurs as the initial clinical sign of SLE in only 3% and 1% of SLE patients, respectively ([@B1]). Pleural effusion typical of SLE is usually yellow-tinged and may be turbid or serosanguineous. It may be neutrophilic or become lymphocytic with time ([@B2]) and the adenosine deaminase (ADA) activity in pleural effusion from patients with SLE is often high. Thus, it is difficult to differentiate SLE from tuberculous pleurisy, pulmonary embolism, congestive heart failure, parapneumonic effusion, and nephrotic syndrome ([@B2]).

To date, there have only been 6 reported cases of SLE with pleural effusion as the initial manifestation reported in the English literature ([Table](#t001){ref-type="table"}) ([@B3]-[@B8]). Two of the six cases involved elderly patients, and in all cases, the effusion was bilateral and exudative. In addition, all previous case reports noted little systemic involvement apart from pleural effusion, making an accurate diagnosis challenging. All of the patients in our cases were elderly, and three of the four patients were men with cardiovascular disease and bilateral pleural effusion resulting in an initial, erroneous clinical diagnosis of congestive heart failure.

###### 

Clinical Features of SLE Cases with Pleuritis as the Initial Presenting Clinical Sign.

  Reference                     3                                       4                                   5                                      6                                                            7                             8                                                        Case 1                                                        Case 2                                   Case 3                          Case 4
  ----------------------------- --------------------------------------- ----------------------------------- -------------------------------------- ------------------------------------------------------------ ----------------------------- -------------------------------------------------------- ------------------------------------------------------------- ---------------------------------------- ------------------------------- -----------------------------
  Age                           20                                      23                                  66                                     80                                                           20                            33                                                       75                                                            69                                       80                              83
  Gender                        Female                                  Female                              Male                                   Male                                                         Male                          Female                                                   Male                                                          Male                                     Female                          Male
  C.C.                          Dyspnea                                 Chest pain                          Dyspnea                                Dyspnea                                                      Dyspnea                       Dyspnea                                                  Dyspnea                                                       Chest pain                               Fever                           None
  ANA                           1:160 Homogenous                        1:320, Speckled                     1:1,280 Speckled                       1:320                                                        1:350                         Positive                                                 1:40                                                          1:2,560 Homogenous                       1:2,560 Homogenous              1:40-1:80 Homogenous
  Anti-dsDNA                    98 ng/dL                                1:320                               1:160                                  119 ng/dL                                                    Positive                      1:640                                                    7 ng/dL                                                       95 ng/dL                                 4 ng/dL                         33-84 ng/dL
  Classification Criteria^\*^   N/R                                     N/R                                 N/R                                    N/R                                                          N/R                           N/R                                                      Leukopenia Thrombocytopenia Low complement Urinary RBC cast   Proteinuria Anti-cardiolipin             Proteinuria Low complement      N/A
  Pleural effusion              Bilateral Exudate Neut 80%, Lymph 20%   Left side Exudate                   Bilateral Exudate Neut 92%, Lymph 4%   Bilateral Exudate                                            Bilateral Exudate Lymph 70%   Bilateral Exudate                                        Bilateral Exudate Lymph 82.5%                                 Bilateral Exudate Neut 35.5% Lymph 24%   Left side Exudate Lymph 4-60%   Bilateral Exudate Lymph 73%
  ADA                           23 U/L                                  N/R                                 N/R                                    N/R                                                          N/R                           22.8 U/L                                                 54.2 U/L                                                      89.0 U/L                                 22.5 U/L                        175.1 U/L
  Treatment                     mPSL 1 mg/kg/day                        mPSL 2 mg/kg/day +MTX 7.5 mg/week   mPSL 1 mg/kg/day                       mPSL (500 mg×3 days) followed by mPSL 1 mg/kg/day +HCQ+MMF   PSL 50 mg/day                 mPSL (500 mg×3 days) followed by mPSL 1 mg/kg/day +HCQ   mPSL 60 mg/day                                                mPSL 60 mg every other day               mPSL 30 mg/day                  Aspirin 600 mg/day
  Outcome                       Improved                                Improved                            Improved                               Improved                                                     Improved                      Improved                                                 Improved                                                      Improved                                 Improve                         Improved

\* Systemic Lupus International Collaborating Clinics classification criteria

C.C.: chief complain, N/R: not reported, N/A: not applicable, RBC: red blood cell, ANA: antinuclear antibody, Neut: neutrophil, Lymph: lymphocyte, PSL: prednisolone, mPSL: methylprednisolone, MTX: methotrexate, HCQ: hydroxylchloroquine, MMF: mycophenolate mofetil

Previous studies have described that patients with late-onset SLE experience less mucocutaneous and renal effects, but more serositis ([@B9],[@B10]). Another study reported that SLE most commonly affects women, with the percentage of females in affected populations ranging from 88.3 to 96.2% ([@B11]). Thoracentesis is important for further evaluating elderly patients with bilateral pleural effusion that is resistant to diuretic treatment for suspected heart failure.

As all of the pleural effusions in our patients were lymphocytic, and as the ADA activity was high in 3 of the 4 patients, it was difficult to differentiate SLE from tuberculous pleurisy. Good et al. reported that 50% of patients with lupus pleuritis have a predominance of mononuclear leukocytes in their effusion ([@B2]). It has been demonstrated that pleural fluid ADA activity is often high in SLE (mean value, 33.3 U/L) ([@B12]). Cultivation tests and histopathology must be considered when tuberculous pleurisy is suspected.

In conclusion, we reported four cases in which pleuritis was the initial manifestation of SLE. In all cases, clinical findings unrelated to the pleural effusion ultimately led to an accurate diagnosis. Consequently, it is important to focus on other findings besides the pleural effusion when investigating pleural effusion of unknown origin. Physical examinations, blood tests, and urinalyses often provide important clues that can lead to a correct final diagnosis.
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